Early Access

Back to COR

Cencora, Inc. Cash & Equivalents 2006-2026 | COR

Beta

What is cash & equivalents?

Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.

What is Cencora, Inc.'s current cash & equivalents?

Cencora, Inc. (COR) annual cash & equivalents for 2025 was $4.36B, a 39.06% increase from 2024. Cencora, Inc. cash & equivalents for the quarter ending December 31, 2025 was $1.75B.

What was Cencora, Inc.'s cash & equivalents in 2024?

Cencora, Inc. annual cash & equivalents for 2024 was $3.13B, a 20.86% increase from 2023.

What was Cencora, Inc.'s cash & equivalents in 2023?

Cencora, Inc. annual cash & equivalents for 2023 was $2.59B, a 23.50% decline from 2022.

What is Cencora, Inc.'s 5-year cash & equivalents CAGR?

Cencora, Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 1.07% from FY2020 to FY2025, going from $4.60B to $4.36B over 5 years.

Cash & Equivalents History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR-1.1%
FY2020
$4.60B
→
FY2025
$4.36B
0607080910111213141516171819202122232425
5 years selected
Cash & Equivalents History
PeriodValueChangeSource
FY2025$4.36B+39.1%10-K
FY2024$3.13B+20.9%10-K
FY2023$2.59B-23.5%10-K
FY2022$3.39B+33.0%10-K
FY2021$2.55B-44.6%10-K
FY2020$4.60B+36.3%10-K
FY2019$3.37B+35.4%10-K
FY2018$2.49B+2.4%10-K
FY2017$2.44B-11.2%10-K
FY2016$2.74B+26.5%10-K
FY2015$2.17B+19.8%10-K
FY2014$1.81B+46.9%10-K
FY2013$1.23B+15.4%10-K
FY2012$1.07B-41.6%10-K
FY2011$1.83B+10.1%10-K
FY2010$1.66B+64.3%10-K
FY2009$1.01B+14.9%10-K
FY2008$878.1M+37.2%10-K
FY2007$640.2M-49.2%10-K
FY2006$1.26B-10-K
Company: Cencora, Inc.Ticker: CORSector: HealthcareIndustry: Wholesale-Drugs, Proprietaries & Druggists' SundriesView company profile →